Standard Chartered PLC (“StanChart”) plans to issue new SGD NC5.5 AT1 perpetuals at an initial price guidance (“IPG”) of 4.70%. StanChart will have the option to call the bond anytime from 15 July 2031 (Year 5.5) to the first reset date of 15 January 2032 (Year 6) or on any subsequent reset date where subsequent reset dates will be every 5 years thereafter (e.g., 15 January 2037).
The issuer is rated A3 by Moody’s, BBB+ by S&P, and A by Fitch. The bond is expected to be rated Ba1 by Moody’s, BB+ by S&P, and BBB- by Fitch. Net proceeds will be used for the general business purposes of the Group and to further strengthen the regulatory capital base of the Group.
We provide a quick update on StanChart’s financials below, but broadly speaking, we think StanChart continues to be a solid issuer who should have no issues meeting its debt obligations.
Financial Highlights:
For the third quarter ending 30 September 2025 (“3Q2025”), underlying operating income rose 5% year-on-year (“YoY) to USD$5.15b on a constant currency (“CC”) basis. This was due to a 12% YoY growth in non-net interest income, while net interest income was flat (-1% YoY). Net interest income came in flat (-1% YoY) as an increase in average interest-earning assets (+ USD$58m) was offset by a decline in rates and margins owing to a lower interest rate environment. Meanwhile, non-net interest income continues to benefit from the Wealth Solutions segment, which saw a double-digit growth amidst continued strong net inflows.
Meanwhile, operating expenses in 3Q2025 grew by a similar margin: +4% YoY to USD$2.95b in constant currency terms. A large portion of this increase was a USD$227m attributed to business growth, mainly to support the corporate & investment bank (CIB) and Affluent Wealth & Retail Banking (WRB) business segments.
Underlying profit before taxation (PBT) rose 9% YoY in 3Q2025 to USD$1.99b (3Q2024: USD$1.81b). This was mainly driven by higher underlying operating income highlighted earlier We also highlight that reported PBT growth came in much lower at just +3% YoY (compared to the 9% for underlying), mainly due to restructuring costs of USD$54m as well as other costs of USD$165m due to ongoing transformation cost from its Fit for Growth (“FFG”) programme. Nonetheless, we like that StanChart remains profitable in its core banking business, with drivers seen in its less rate-sensitive segments (Wealth Management) while its rate-sensitive (net interest income) segment remains resilient.
Outlook:
Management has maintained its guidance for FY25 net interest income at roughly USD$10b, down low single digit YoY in constant currency terms. This gives rise to one important risk: if lower actual rates (aggressive rate cuts) materialise, StanChart could see further headwinds on its rates-sensitive segments. Nonetheless, for us, given that we do not expect drastic rate cuts and think market expectations are overdone, we think net interest income could remain supported.
Meanwhile, cost management continues to be a focus of the company and its ‘Fit for Growth’ program. They have maintained their guidance for USD$1.5b in cost savings from 2024 to 2026, with a big part of this USD$1.5b (~85% run-rate savings) to be delivered by the end of 2026, with USD$600m already saved so far by 3Q2025. We think this (if successful) could continue supporting this issuer’s profitability.
Finally, we highlight that management has recently upgraded its guidance in 3Q2025 for 2025 operating income. Operating income is now expected to increase above 7% in 2024, excluding two notable items in 1Q24 (previously ‘around the top of the 5-7% range’). We are not overly surprised – as mentioned previously, the 5-7% range appeared to be conservative, especially when compared to previous guidance. Considering (i) our view of not expecting drastic rate cuts supporting rates-sensitive segments; (ii) strong growth observed in other segments like Wealth Management; and (iii) good progress made in cost savings, we think StanChart remains well-placed to deliver positive earnings growth in the years ahead.
Additionally, management is also guiding to increased profitability, with a ROTE of 13% exiting 2025, reaching their target a year early. This target achievement on an accelerated timeframe supports our view of positive earnings growth in the years ahead.
Credit Profile:
StanChart’s loan-loss rate remained decent at 24bps in 3Q2025, comparable to the previous quarters (2Q2025: 12bps / 1Q2025: 25bps), despite a slight increase in credit impairment. Broadly speaking, we believe StanChart’s asset quality is resilient, and we do not expect any significant signs of stress.
StanChart’s CET1 ratio was reported at 14.2%, flat from 31 December 2024. This remains well above the regulatory minimum of 10.3% and above management’s target range of 13% to 14%. Do note that this 14.2% figure accounts for the full USD$1.3b share buyback programme the bank has in place. We reiterate our previous stance that StanChart’s CET1 ratio remains healthy and could even see further uplifts from profit accretion in the coming quarters.
Finally, we also highlight that its leverage ratio of 4.6% and liquidity coverage ratio of 151% remain healthy and stable (at least relative to previous quarters).
In all, we continue to find that StanChart’s key solvency ratios remain healthy, with decent buffers over regulatory minimums.
Recommendation:
Table 1: SGD perpetual bonds
|
Bond Issue |
Years to Call |
Ask Price |
Yield to Next Worst (%) |
Credit Rating (S&P / Moody’s / Fitch) |
|
STANLN New Issue |
5.500 |
100.000* |
4.700% |
BB+ / Ba1 / BBB- |
|
2.144 |
103.900 |
3.977% |
BBB- / - / BBB |
|
|
5.491 |
101.650 |
4.333% |
- / Ba1 / BBB- |
|
|
4.188 |
103.067 |
4.590% |
- / Ba1 / BBB- |
|
|
2.440 |
106.800 |
4.343% |
- / Ba1 / BBB- |
|
|
1.689 |
106.753 |
4.134% |
- / Ba1 / BBB- |
|
|
4.733 |
102.582 |
2.418% |
BBB- / Baa1 / - |
|
|
3.111 |
106.766 |
2.230% |
BBB- / Baa1 / BBB+ |
|
|
1.418 |
102.750 |
1.924% |
BBB- / Baa1 / BBB+ |
|
|
3.777 |
106.300 |
2.296% |
BBB- / Baa1 / BBB+ |
|
|
1.519 |
106.183 |
4.009% |
BB / Ba2 / BB+ |
|
|
3.623 |
105.250 |
4.171% |
- / Baa3 / BBB- |
|
|
3.958 |
104.950 |
4.227% |
- / Baa3 / BBB- |
|
|
*Not yet issued. Yield is based on IPG and is likely to be revised downwards. (“FPG”) Source: Bondsupermart, Bloomberg, iFAST Compilations. Data as of 6 January 2026. |
||||
We compare StanChart’s latest issue with other SGD perpetuals issued by major banks. Factoring in the likelihood of the final price guidance (“FPG”) adjusting downwards and comparing perpetuals with similar credit ratings (Moody’s and Fitch) such as Barclays, we find these new StanChart perpetuals to be fairly priced.
Investors should be mindful of risks associated with AT1s, such as the loss-absorption risks involved and the possibility of non-call risks. We think that investors should demand adequate compensation for such risks.
Declaration: For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) holds a position in BACR 4.650% Perpetual Corp (SGD), BACR 8.300% Perpetual Corp (SGD), and OCBCSP 3.900% Perpetual Corp (SGD). The analyst who produced this report holds a NIL position in the abovementioned securities.
All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.
Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).
iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.
Please note that only certain bond(s) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to Fundsupermart.com's prevailing policies and procedures. Please read our full disclaimers in the website.